1461086434-c7c86b7a-4f9a-45d0-a7a0-8dae3c1a1f77

1. A fixing system for a skirting, said system comprising a skirting profile element and a coupling element, the skirting profile element having an arm to engage the upper surface of floor covering and configured to connect with the coupling element, the arm having a portion extending upwardly towards a wall, in use;
the coupling element comprising a first end portion that is substantially flat and adapted to be located under the floor covering, and a second end portion having a portion extending towards the floor covering, downwardly so that, in use, the downwardly extending portion of the coupling element bears against the upwardly extending portion of the arm to connect the coupling element with and on top of the arm of the skirting profile element, the coupling element being flexible and having a bent portion between the first and second end portions so that, in use, the second end portion can connect with the arm of the skirting profile element in a separable manner.
2. A fixing system as claimed in claim 1, wherein the arm of the skirting profile element and the coupling element are connectable in a snap-fit manner.
3. A fixing system as claimed in claim 1, wherein the coupling element is provided with a reinforcing web.
4. A fixing system as claimed in claim 1, wherein the bent portion of the coupling element has a flattened portion for abutting the wall.
5. A fixing system as claimed in claim 1, wherein the coupling element is provided with flexible inserts.
6. A fixing system for a skirting as claimed in claim 1, wherein the coupling element is provided with a leveling flexible element comprising an end configured to bear against a portion of the floor covering.
7. A fixing system as claimed in claim 1, wherein the arm of the skirting profile element has an upright protrusion for engaging the coupling element.
8. A fixing system as claimed in claim 1, wherein the downwardly extending portion of the second end portion of the coupling element forms a portion of a triangular recess configured to engage with an undercutting formed by the upwardly extending portion of the arm of the skirting profile element to connect the coupling element with and on top of the arm of the skirting profile element.
9. A fixing system as claimed in claim 1, wherein an end of the arm of the skirting profile element is configured to extend in a direction towards the wall.
10. A fixing system as claimed in claim 1, wherein the bent portion is configured to bear against the wall when the coupling element is connected with and on top of the arm of the skirting profile element.
11. A fixing system as claimed in claim 1, wherein the downwardly extending portion of the coupling element further comprises a first engagement surface and the upwardly extending portion of the arm of the skirting profile element further comprises a second engagement surface so that, in use, the first and second engagement surfaces are configured to engage with each other to connect the coupling element with and on top of the arm of the skirting profile element.
12. A fixing system as claimed in claim 11, wherein the first engagement surface is a lower surface on the underside of the coupling element and the second engagement surface is an upper surface on the top of the arm.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A compound of Formula 1 or a pharmaceutically acceptable salt thereof:
wherein R1, R2, R3 and R4 are independently hydrogen or a non-hydrogen substituent selected from the group consisting of C1-12 alkyl unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C3-10 cycloalkyl, C5-12 aryl, C5-12 heteroaryl, hydroxyl, halogen and C1-4 alkoxycarbonyl; C3-10 cycloalkyl; C1-12 alkoxy; C5-12 aryl; C5-12 heteroaryl; hydroxyl; and halogen, and
the aryl and heteroaryl are unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C1-4 alkyl, C1-4 alkoxy, hydroxyl and halogen.
2. The compound of Formula 1 or a pharmaceutically acceptable salt thereof of claim 1, wherein R1, R2, R3 and R4 are independently hydrogen or a non-hydrogen substituent selected from the group consisting of unsubstituted C1-7 alkyl; C1-6 alkyl substituted with at least one non-hydrogen substituent selected from the group consisting of unsubstituted C3-7 cycloalkyl, C5-12 aryl, C5-12 heteroaryl, hydroxyl, halogen and C1-4 alkoxycarbonyl; unsubstituted C3-7 cycloalkyl; C1-6 alkoxy; C5-12 aryl; C5-12 heteroaryl; hydroxyl; and halogen, and
the aryl and heteroaryl are unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C1-4 alkyl, C1-4 alkoxy, hydroxyl and halogen.
3. The compound of Formula 1 or a pharmaceutically acceptable salt thereof of claim 2, wherein R1 and R4 are independently non-hydrogen substituents selected from the group consisting of unsubstituted C1-7 alkyl; C1-6 alkyl substituted with at least one non-hydrogen substituent selected from the group consisting of unsubstituted C3-7 cycloalkyl, C5-12 aryl, C5-12 heteroaryl and C1-4 alkoxycarbonyl; unsubstituted C3-7 cycloalkyl; C5-12 aryl; and C5-12 heteroaryl,
R2 and R3 are hydrogen; unsubstituted C1-7 alkyl; C5-12 aryl; or C5-12 heteroaryl, and
the aryl and heteroaryl are unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C1-4 alkyl, C1-4 alkoxy, hydroxyl and halogen.
4. The compound of Formula 1 or a pharmaceutically acceptable salt thereof of claim 3, wherein R1 and R4 are independently non-hydrogen substituents selected from the group consisting of unsubstituted C1-7 alkyl; C1-4 alkyl substituted with at least one non-hydrogen substituent selected from the group consisting of unsubstituted C3-7 cycloalkyl, C5-12 aryl, C5-12 heteroaryl and C1-4 alkoxycarbonyl; unsubstituted C3-7 cycloalkyl; C5-12 aryl; and C5-12 heteroaryl,
R2 and R3 are hydrogen; unsubstituted C1-7 alkyl; C5-12 aryl; or C5-12 heteroaryl, and
the aryl and heteroaryl may be unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C1-4 alkoxy, hydroxyl and halogen, and the aryl and heteroaryl may be selected from the group consisting of phenyl, pyridinyl, furanyl and isoquinolinyl.
5. The compound of Formula 1 or a pharmaceutically acceptable salt thereof of claim 4, wherein R1 is unsubstituted C1-7 alkyl; C1-4 alkyl substituted with C5-12 aryl or C5-12 heteroaryl; C5-12 aryl; or C5-12 heteroaryl,
R2 is hydrogen; or unsubstituted C1-7 alkyl,
R3 is hydrogen; unsubstituted C1-7 alkyl; C5-12 aryl; or C5-12 heteroaryl,
R4 is a non-hydrogen substituent selected from the group consisting of unsubstituted C1-7 alkyl; C1-4 alkyl substituted with at least one non-hydrogen substituent selected from the group consisting of unsubstituted C3-7 cycloalkyl, C5-12 aryl, C5-12 heteroaryl and C1-4 alkoxycarbonyl; unsubstituted C3-7 cycloalkyl; C5-12 aryl; and C5-12 heteroaryl, and
the aryl and heteroaryl may be unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C1-4 alkoxy, hydroxyl and halogen, and the aryl and heteroaryl may be selected from the group consisting of phenyl, pyridinyl, furanyl and isoquinolinyl.
6. The compound of Formula 1 or a pharmaceutically acceptable salt thereof of claim 1, wherein the compound of Formula 1 is N1-hexyl-N5-propyl biguanide; N1-hexyl-N5-cyclopropylmethyl biguanide; N1-hexyl-N5-cyclohexylmethyl biguanide; N1-hexyl-N5-benzyl biguanide; N1,N5-bis(4-chlorophenyl) biguanide; N1,N5-bis(3-chlorophenyl)biguanide; N1-(4-chloro)phenyl-N5-(4-methoxy)phenyl biguanide; N1,N5-bis(3-chloro-4-methoxyphenyl)biguanide; N1,N5-bis(3,4-dichlorophenyl) biguanide; N1,N5-bis(3,5-dichlorophenyl)biguanide; N1,N5-bis(4-bromophenyl)biguanide; N1-benzyl-N5-(pyridine-3-yl)methyl biguanide; N1-(phenethyl)-N5-propyl biguanide; N1-(phenethyl)-N5-cyclopropylmethyl biguanide; N1-(phenethyl)-N5-cycloheptyl biguanide; N1,N5-bis(phenethyl)biguanide; N1,N1,N5-trimethyl biguanide; N1,N1-dimethyl-N5-butyl biguanide; N1,N1-dimethyl-N5-(butan-2-yl)biguanide; N1,N1-dimethyl-N5-t-butyl biguanide; N1,N1-dimethyl-N5-pentyl biguanide; N1,N1-dimethyl-N5-methoxycarbonylethyl biguanide; N1,N1-dimethyl-N5-cycloheptyl biguanide; N1,N1-dimethyl-N5-cyclopropylmethyl biguanide; N1,N1-dimethyl-N5-(4-bromo)phenyl biguanide; N1,N1-dimethyl-N5-(furan-2-yl)methyl biguanide; N1,N1-dimethyl-N5-(pyridine-3-yl)methyl biguanide; N1,N1-dimethyl-N5-benzyl biguanide; N1,N1-dimethyl-N5-(phenethyl)biguanide; N1,N1-diethyl-N5-(3-chloro)phenyl biguanide; N1,N1-dipropyl-N5-(3-chloro)phenyl biguanide; N1,N1-(ethyl)(propyl)-N5-(4-chloro)phenyl biguanide; N1,N1-dipropyl-N5-(isoquionline-5-yl)biguanide; N1,N1-dihexyl-N5-(3-chloro)phenyl biguanide; N1,N1,N5,N5-tetraethyl biguanide; N1,N1-diethyl-N5,N5-(cyclohexyl)(methyl)biguanide; N1,N1-dipropyl-N5,N5-diethyl biguanide; N1,N1-dipropyl-N5,N5-(methyl)(phenethyl)biguanide; N1,N1-dipropyl-N5,N5-(4-hydroxylphenyl)(phenyl) biguanide; or N1,N1,N5,N5-bis((benzyl)(methyl))biguanide.
7. The compound of Formula 1 or a pharmaceutically acceptable salt thereof of claim 1, wherein the pharmaceutically acceptable salt is a salt with an acid selected from the group consisting of formic acid, acetic acid, propionic acid, lactic acid, butyric acid, isobutylc acid, trifluoroacetic acid, malic acid, maleic acid, malonic acid, fumaric acid, succinic acid, succinic acid monoamide, glutamic acid, tartaric acid, oxalic acid, citric acid, glycolic acid, glucuronic acid, ascorbic acid, benzoic acid, phthalic acid, salicylic acid, anthranyl acid, benzensulfonic acid, p-toluenesulfonic acid, methanesulfonic acid, dichloroacetic acid, aminooxy acetic acid, hydrochloric acid, bromic acid, sulfuric acid, phosphoric acid, nitric acid, carbonic acid and boric acid.
8. A method of preparing a compound of Formula 1, comprising:
reacting a compound of Formula 2 with dicyanoamide in at least one organic solvent to obtain a compound of Formula 3; and
reacting the compound of Formula 3 with a compound of Formula 4 in at least one organic solvent to obtain the compound of Formula 1:
Wherein R1, R2, R3 and R4 are independently hydrogen or a non-hydrogen substituent selected from the group consisting of C1-12 alkyl unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C3-10 cycloalkyl, C5-12 aryl, C5-12 heteroaryl, hydroxyl, halogen and C1-4 alkoxycarbonyl; C3-10 cycloalkyl; C1-12 alkoxy; C5-12 aryl; C5-12 heteroaryl; hydroxyl; and halogen, and
the aryl and heteroaryl are unsubstituted or substituted with at least one non-hydrogen substituent selected from the group consisting of C1-4 alkyl, C1-4 alkoxy, hydroxyl and halogen.
9. A drug comprising a compound of Formula 1 or a pharmaceutically acceptable salt thereof according to claim 1 as an active ingredient.
10.-16. (canceled)
17. A method of treating a disease, comprising:
administering a therapeutically effective amount of a compound of Formula 1 or a pharmaceutically acceptable salt thereof according to claim 1 to a subject in need thereof, wherein the disease is selected from the group consisting of diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, muscle pain, myocyte damage and rhabdomyolysis.
18. The method of claim 17, wherein diabetes mellitus is insulin independent mellitus.
19. The method of claim 17, wherein the cancer is breast cancer, colorectal cancer, gastric cancer, liver cancer, lung cancer, blood cancer, prostate cancer, brain cancer, pancreatic cancer, ovarian cancer, or endometrial cancer.

1461086423-2e2abec2-918b-43d4-ad81-42f06c61a1d2

What is claimed is:

1. A laminated ultrasonic waveguide comprising at least two stamped pieces of sheet stock which are laminated together to form a laminated ultrasonic waveguide for transferring ultrasonic acoustic energy along a longitudinal axis of the laminated ultrasonic waveguide.
2. The laminated ultrasonic waveguide of claim 1, in an ultrasonic surgical instrument having an active tip end-effector which is placed in contact with tissue of a patient to couple ultrasonic energy transferred along the laminated ultrasonic waveguide to the tissue.
3. The laminated ultrasonic waveguide of claim 1, wherein the at least two stamped pieces of sheet stock are stamped to form at least one channel extending along the length of the laminated ultrasonic waveguide.
4. The laminated ultrasonic waveguide of claim 1, wherein the laminated ultrasonic waveguide defines a connector at a proximal end of the laminated ultrasonic waveguide to transfer ultrasonic energy to the laminated ultrasonic waveguide.
5. The laminated ultrasonic waveguide of claim 1, comprising first and second stamped half pieces of sheet stock which are laminated together, wherein each of the stamped first and second half pieces of sheet stock defines half of a cylindrical connector at a proximal end of the laminated ultrasonic waveguide which has threads stamped into an interior surface of each half cylindrical connector, such that the first and second half pieces define a cylindrical connector having threads on the interior surface thereof for providing a threaded connector to the laminated ultrasonic waveguide.
6. The laminated ultrasonic waveguide of claim 1, wherein a distal portion of each of the stamped pieces of sheet stock has a longitudinal rib stamped therein extending along the longitudinal axis of the laminated ultrasonic waveguide to provide lateral stiffness for the laminated ultrasonic waveguide.
7. The laminated ultrasonic waveguide of claim 1, wherein the ultrasonic waveguide comprises first outer, second inner and third outer stamped pieces of sheet stock which are laminated together, wherein each of the first, second and third stamped pieces of sheet stock defines a portion of a cylindrical connector at a proximal end of the laminated ultrasonic waveguide which has threads stamped into an interior surface of the cylindrical connector, such that the first, second and third stamped pieces define the cylindrical connector having threads stamped into the interior surface of the cylindrical connector for providing a threaded connector to the laminated ultrasonic waveguide.
8. The laminated ultrasonic waveguide of claim 7, wherein the first and third outer laminated pieces of sheet stock extend from the proximal end of the ultrasonic waveguide for a portion of the length of the ultrasonic waveguide, and the second inner laminated piece of sheet stock extends for at least a portion of the length of the ultrasonic waveguide.
9. The laminated ultrasonic waveguide of claim 8, wherein the second inner laminated piece of sheet stock extends to a distal active tip end of the laminated ultrasonic waveguide.
10. The laminated ultrasonic waveguide of claim 9, wherein the second inner laminated piece forms an end-effector at the distal end of the ultrasonic laminated waveguide.
11. The ultrasonic waveguide of claim 1, wherein a piece of sheet stock is mounted and secured to longitudinally extending slots in an outer circumference of a separate threaded connector.
12. A method of fabricating a laminated ultrasonic waveguide comprising stamping and forming at least two stamped pieces of sheet stock to form parts of the body of the laminated ultrasonic waveguide, and laminating together the at least two stamped pieces of sheet stock to form the body of the laminated ultrasonic waveguide.
13. The method of claim 12, further comprising fabricating an ultrasonic surgical instrument comprising an active tip end-effector which is placed in contact with tissue of a patient to couple ultrasonic energy transferred along the longitudinal axis of the laminated ultrasonic waveguide to the tissue.
14. The method of claim 12, including stamping the at least two stamped pieces of sheet stock to form at least one channel extending along a length of the laminated ultrasonic waveguide.
15. The method of claim 12, further comprising defining a connector at a proximal end of the laminated ultrasonic waveguide to transfer ultrasonic energy to the laminated ultrasonic waveguide.
16. The method of claim 12, including stamping and forming first and second half pieces of sheet stock while defining in each of the stamped first and second half pieces of sheet stock half of a cylindrical connector at a proximal end of the laminated ultrasonic waveguide by stamping threads into an interior surface of each half of the cylindrical connector, such that the first and second half pieces define a cylindrical connector having threads on the interior surface thereof for providing a threaded connector to the laminated ultrasonic waveguide.
17. The method of claim 12, including stamping and forming a longitudinal rib in a distal portion of each of the stamped pieces of sheet stock which extends along a longitudinal axis of the laminated ultrasonic waveguide to provide lateral stiffness for the laminated ultrasonic waveguide.
18. The method of claim 12, including stamping and forming first outer, second inner and third outer stamped pieces of sheet stock while defining in each of the first, second and third stamped pieces of sheet metal a portion of a cylindrical connector at a proximal end of the laminated ultrasonic waveguide by stamping threads into an interior surface of the cylindrical connector, such that the first, second and third stamped pieces define the cylindrical connector having threads stamped into the interior surface of the cylindrical connector for providing a threaded connector to the ultrasonic waveguide.
19. The method of fabricating an ultrasonic surgical instrument of claim 17, including stamping and forming the first and third outer laminated pieces of sheet stock to extend from the proximal end of the laminated ultrasonic waveguide for a portion of the length of the laminated ultrasonic waveguide, and stamping and forming the second inner laminated piece of sheet stock to extend for at least a portion of the length of the laminated ultrasonic waveguide.
20. The method of claim 19, including forming the second inner laminated piece of sheet stock to extend to a distal tip end of the laminated ultrasonic waveguide.
21. The method of claim 20, including stamping and forming the second inner laminated piece with an end-effector tip at the distal end of the laminated ultrasonic waveguide.
22. The method of claim 12, including mounting and securing a piece of sheet stock to longitudinally extending slots in an outer circumference of a separate threaded connector.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method of processing a digital television (DTV) signal in a DTV receiver, the method comprising:
receiving a digital television signal including a plurality of extended text table (ETT) instances that appear in transport stream packets with common PID values, the ETT instances having common table ID values, each ETT instance comprising a section header and a message body, the section header containing a table identification (ID) extension field that serves to establish uniqueness of each ETT instance, the message body containing an extended text message (ETM) which provides detailed descriptions of a virtual channel or an event associated with each ETT instance, wherein the section header further contains a last section number field, wherein the ETT instance further contains a CRC 32 field;
demodulating the digital television signal; and
identifying at least one pertinent ETT instance from the plurality of ETT instances.
2. The method of claim 1, wherein the last section number field is a 8-bit field and the CRC 32 field is a 32-bit field.
3. The method of claim 1, wherein the table ID extension field defines a value indicating an event identifier (ID) associated with each ETT instance.
4. The method of claim 2, wherein the table ID extension field further defines a value indicating an ETM location.
5. The method of claim 1, wherein the table ID extension field has a 16-bit integer value.
6. The method of claim 1, wherein the plurality of ETT instances are section-filtered based on a condition that the at least one pertinent ETT instance has a specific PID value.
7. The method of claim 1, wherein the plurality of ETT instances are section-filtered based on a condition that the table ID extension field included in the at least one pertinent ETT instance includes a specific value.
8. The method of claim 7, wherein the specific value specifies a unique identification number of an event associated with the at least one pertinent event ETT instance.
9. The method of claim 1, wherein the plurality of ETT instances are section-filtered based on a condition that the table ID extension field included in the at least one pertinent ETT instance includes a non-duplicative event identifier.
10. The method of claim 1, further comprising:
parsing the identified at least one pertinent ETT instance; and
storing the extended text message (ETM) included in the parsed ETT instance.
11. A method of processing a digital television (DTV) signal in a DTV transmitter, the method comprising:
generating a plurality of extended text table (ETT) instances that appear in transport stream packets with common PID values, the ETT instances having common table ID values, each ETT instance comprising a section header and a message body, the section header containing a table identification (ID) extension field that serves to establish uniqueness of each ETT instance, the message body containing an extended text message (ETM) which provides detailed descriptions of a virtual channel or an event associated with each ETT instance, wherein the section header further contains a last section number field, wherein the ETT instance further contains a CRC 32 field;
multiplexing the ETT instances and audio and video (AV) data; and
transmitting a DTV signal including the multiplexed ETT instances and AV data.
12. The method of claim 11, wherein the last section number field is a 8-bit field and the CRC 32 field is a 32-bit field.
13. The method of claim 11, wherein the table ID extension field defines a value indicating an event identifier (ID) associated with each ETT instance.
14. The method of claim 13, wherein the table ID extension field further defines a value indicating an ETM location.
15. The method of claim 11, wherein the table ID extension field has a 16-bit integer value.
16. The method of claim 11, wherein the plurality of ETT instances are section-filtered based on a condition that at least one pertinent ETT instance has a specific PID value.
17. The method of claim 11, wherein the plurality of ETT instances are section-filtered based on a condition that the table ID extension field included in at least one pertinent ETT instance includes a specific value.
18. The method of claim 17, wherein the specific value specifies a unique identification number of an event associated with the at least one pertinent ETT instance.
19. The method of claim 11, wherein the plurality of ETT instances are section-filtered based on a condition that the table ID extension field included in at least one pertinent ETT instance includes a non-duplicative event identifier.
20. The method of claim 11, further comprising:
multiplexing at least one pertinent ETT instance; and
transmitting the extended text message (ETM) included in the multiplexed ETT instance.